Literature DB >> 20888934

De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins.

Aurelio Hernandez-Lain1, Isabelle Husson, Nicole Monnier, Caroline Farnoux, Guy Brochier, Emmanuelle Lacène, Maud Beuvin, Mait Viou, Linda Manéré, Kristl G Claeys, Michel Fardeau, Joël Lunardi, Thomas Voit, Norma Beatriz Romero.   

Abstract

"Core-rod myopathy" is a rare congenital myopathy characterized by the presence of "cores" and "rods" in distinct locations in the same or different muscle fibres. This association is linked currently to mutations in RYR1, NEB and ACTA1 genes. We report identical twins who presented with polyhydramnios and loss of fetal motility during pregnancy; hypotonia, arthrogryposis and swallowing impairment at birth; need of immediate respiratory support and death at 27 and 50 days of life. Muscle biopsies, performed at 27 days of life in twin 1 and at 49 days in twin 2, showed the presence of separate cores and rods in the muscle fibres, both at light and electron microscopy. The molecular analysis showed a heterozygous de novo mutation (Ile4898Thr) of the RYR1 gene. The molecular study of ACTA1, TMP2 and TMP3 genes did not show abnormalities. This is the first report of a lethal form of congenital "core-rod myopathy". The mutation Ile4898Thr has been previously described in central core disease but not in core-rod myopathy. The report enlarges the phenotypic spectrum of "core-rod myopathy" and highlights the morphological variability associated to special RYR1 mutations.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888934     DOI: 10.1016/j.ejmg.2010.09.009

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  14 in total

1.  Mouse model of severe recessive RYR1-related myopathy.

Authors:  Stephanie Brennan; Maricela Garcia-Castañeda; Antonio Michelucci; Nesrin Sabha; Sundeep Malik; Linda Groom; Lan Wei LaPierre; James J Dowling; Robert T Dirksen
Journal:  Hum Mol Genet       Date:  2019-09-15       Impact factor: 6.150

2.  Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype.

Authors:  Valerie De Crescenzo; Kevin E Fogarty; Jason J Lefkowitz; Karl D Bellve; Elena Zvaritch; David H MacLennan; John V Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 3.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

4.  Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies.

Authors:  Ann E Davidson; Fazeel M Siddiqui; Michael A Lopez; Peter Lunt; Heather A Carlson; Brian E Moore; Seth Love; Donald E Born; Helen Roper; Anirban Majumdar; Suman Jayadev; Hunter R Underhill; Corrine O Smith; Maja von der Hagen; Angela Hubner; Philip Jardine; Andria Merrison; Elizabeth Curtis; Thomas Cullup; Heinz Jungbluth; Mary O Cox; Thomas L Winder; Hossam Abdel Salam; Jun Z Li; Steven A Moore; James J Dowling
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

5.  Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.

Authors:  Romain Lefebvre; Claude Legrand; Estela González-Rodríguez; Linda Groom; Robert T Dirksen; Vincent Jacquemond
Journal:  J Physiol       Date:  2011-10-03       Impact factor: 5.182

6.  Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy.

Authors:  James J Dowling; Sandrine Arbogast; Junguk Hur; Darcee D Nelson; Anna McEvoy; Trent Waugh; Isabelle Marty; Joel Lunardi; Susan V Brooks; John Y Kuwada; Ana Ferreiro
Journal:  Brain       Date:  2012-03-14       Impact factor: 13.501

7.  Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum.

Authors:  Diana Xerxes Bharucha-Goebel; Mariarita Santi; Livija Medne; Kristen Zukosky; Kristin Zukosky; Jahannaz Dastgir; Perry B Shieh; Thomas Winder; Gihan Tennekoon; Richard S Finkel; James J Dowling; Nicole Monnier; Carsten G Bönnemann
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

8.  A chemical chaperone improves muscle function in mice with a RyR1 mutation.

Authors:  Chang Seok Lee; Amy D Hanna; Hui Wang; Adan Dagnino-Acosta; Aditya D Joshi; Mark Knoblauch; Yan Xia; Dimitra K Georgiou; Jianjun Xu; Cheng Long; Hisayuki Amano; Corey Reynolds; Keke Dong; John C Martin; William R Lagor; George G Rodney; Ergun Sahin; Caroline Sewry; Susan L Hamilton
Journal:  Nat Commun       Date:  2017-03-24       Impact factor: 14.919

Review 9.  Excitation-Contraction Coupling Alterations in Myopathies.

Authors:  Isabelle Marty; Julien Fauré
Journal:  J Neuromuscul Dis       Date:  2016-11-29

10.  Correlation of phenotype with genotype and protein structure in RYR1-related disorders.

Authors:  Joshua J Todd; Vatsala Sagar; Tokunbor A Lawal; Carolyn Allen; Muslima S Razaqyar; Monique S Shelton; Irene C Chrismer; Xuemin Zhang; Mary M Cosgrove; Anna Kuo; Ruhi Vasavada; Minal S Jain; Melissa Waite; Dinusha Rajapakse; Jessica W Witherspoon; Graeme Wistow; Katherine G Meilleur
Journal:  J Neurol       Date:  2018-08-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.